Current status of single-use process solutions
Learn more: http://goo.gl/c7dg4h
ESACT Meeting 2011 in Vienna
Dr. Thorsten Peuker, Director Marketing and Sales Integrated Solutions, Sartorius Stedim Biotech
http://www.sartorius.com
During the last decade the advent of larger scale single use process solutions have changed our approach to making proteins from cell cultures dramatically. Driven by a growing pipeline of biopharmaceutical drugs in development and the cost pressure that the Pharma industry is experiencing, more and more companies are adopting single use bioreactors up to and beyond the 1000L scale. A similar trend can be observed in downstream processing although probably less matured yet. Membrane adsorption lends itself to single use applications with the potential of combining cell removal, clarification and capture into one unit operation.
A number of companies have already taken the step and implemented hybrid or even single use production facilities for monoclonal antibodies or vaccine production. Saleability of the process and consistency of results from bench-top bioreactors used in process development and as scale-down models in process validation to commercial scale production bioreactors is a key prerequisite for successful drug development. Therefore, ideally the design of the single use bioreactors should be as close as possible to the full scale systems to reduce the number of variables that may influence product quality and process performance.
Finally, with all this different disposable solutions used in GMP production, not only the vendor -- user relationship has changed but also the approach to validation of single use equipment such as bioreactor bags and containers for process fluids.
Видео Current status of single-use process solutions канала Sartorius
ESACT Meeting 2011 in Vienna
Dr. Thorsten Peuker, Director Marketing and Sales Integrated Solutions, Sartorius Stedim Biotech
http://www.sartorius.com
During the last decade the advent of larger scale single use process solutions have changed our approach to making proteins from cell cultures dramatically. Driven by a growing pipeline of biopharmaceutical drugs in development and the cost pressure that the Pharma industry is experiencing, more and more companies are adopting single use bioreactors up to and beyond the 1000L scale. A similar trend can be observed in downstream processing although probably less matured yet. Membrane adsorption lends itself to single use applications with the potential of combining cell removal, clarification and capture into one unit operation.
A number of companies have already taken the step and implemented hybrid or even single use production facilities for monoclonal antibodies or vaccine production. Saleability of the process and consistency of results from bench-top bioreactors used in process development and as scale-down models in process validation to commercial scale production bioreactors is a key prerequisite for successful drug development. Therefore, ideally the design of the single use bioreactors should be as close as possible to the full scale systems to reduce the number of variables that may influence product quality and process performance.
Finally, with all this different disposable solutions used in GMP production, not only the vendor -- user relationship has changed but also the approach to validation of single use equipment such as bioreactor bags and containers for process fluids.
Видео Current status of single-use process solutions канала Sartorius
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Introducing the Incucyte® Live-Cell Analysis System: Antibody InternalizationVirtual Demo of Resolute®️ Flowdrive SU Chromatography SystemIncucyte® Assay software: Incucyte® Spheroid Analysis Software ModuleThe Role of Sartorius’ Lab Water System in PFAS DetectionThe Fast Track to IND: 4Cell® CHO PlatformIntroducing the Incucyte® Live-Cell Analysis System: Virtual ShowroomSurface Plasmon Resonance (SPR) Technology, ExplainedScience Corner: What are the key features of CellCelector?Science Corner: How Does CellCelector Streamline Cell-Line Development?iQue Forecyt®️: The Easy Flow Cytometry Software SolutionAdvances in Live-Cell Imaging and Analysis: Organoids, Metabolism and Subpopulation IdentificationUniSart® Nitrocellulose Membranes: The Substrate of Choice for Protein AssaysDose Accuracy with Cubis® II Laboratory BalancesWebinar (Preview): Cell-Based Therapies for Cancer TreatmentAusbildung bei Sartorius: BiologielaborantinAusbildung bei Sartorius: Kaufleute für E-CommerceRapid Quantitation of AAV Capsids in Bioprocess Development for Gene Therapy Using Octet®️ BLISartorius LifeScienceXplained 2023 | Nominiert: Doktor WhatsonIncucyte® S3 Live-Cell Analysis SystemHow to Make Beautiful Essential Oil Bottles Using Tacta® Mechanical PipettesCAR-T Cell Therapy Research and Development Explained